Keliximab is a human-cynomolgus monkey chimeric (Primatized) monoclonal antibody with specificity for human and chimpanzee CD4.
Practical Aspects of Including Functional Endpoints in Developmental Toxicity Studies. Case Study: Immune Function in HuCD4 Transgenic Mice Exposed to anti-CD4 MAb In Utero
Human and Experimental Toxicology, 2002